Skip to main content

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Featured article: well-being is more than happiness and life satisfaction: a multidimensional analysis of 21 countries

Recent trends on measurement of well-being have elevated the scientific standards and rigor associated with approaches for national and international comparisons of well-being. One major theme in this has been the shift toward multidimensional approaches over reliance on traditional metrics such as single measures (e.g. happiness, life satisfaction) or economic proxies (e.g. GDP).

To read the full research article, click here.


Aims and scope

Health and Quality of Life Outcomes considers original manuscripts on the Health-Related Quality of Life (HRQOL) assessment for evaluation of medical and psychosocial interventions. It also considers approaches and studies on psychometric properties of HRQOL and patient reported outcome measures, including cultural validation of instruments if they provide information about the impact of interventions. The journal publishes study protocols and reviews summarising the present state of knowledge concerning a particular aspect of HRQOL and patient reported outcome measures. Reviews should generally follow systematic review methodology. Comments on articles and letters to the editor are welcome.

Sign up to receive article alerts

Health and Quality of Life Outcomes is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.

Editor profiles

Mark Oremus, co-Editor-in-Chief

Dr Mark Oremus is an Associate Professor in the School of Public Health and Health Systems at the University of Waterloo, Canada. He holds a PhD in Epidemiology and Biostatistics from McGill University.

Dr Oremus' primary research interests include aging and chronic disease, cognition, dementia, and Alzheimer’s disease. He has conducted studies on willingness-to-pay for Alzheimer’s disease medications, measuring quality-of-life in Alzheimer’s disease, and the use of outcome measurement instruments in Alzheimer’s disease drug trials. His other research interests include systematic reviews, population and public health from a life-course perspective, health policy and economics, and knowledge transfer.

Oliver Rivero-Arias, co-Editor-in-Chief

Dr Oliver Rivero-Arias is the Senior Health Economist at the National Perinatal Epidemiology Unit at the University of Oxford, having previously held appointments at the Health Economics Research Centre (HERC), University of Oxford during the period 2002-2013. 

His main research interest concerns the evaluation of cost-effectiveness methodology and the conduct of applied economic studies in the perinatal and maternal health area. He has been involved in the evaluation of methods to handle missing data in cost-effectiveness analysis, the economic implications of cost-effectiveness analysis alongside multinational clinical trials, the development of algorithms to map available data into quality of life measures, and the valuation of health for decision-making.

Annual Journal Metrics